Insider Buying: Electra Therapeutics (NASDAQ:ETRA) Director Buys $19,999,995.00 in Stock September 24, 2026 by InsiderTrades.com Share Key Points Orbimed Advisors, a director of Electra Therapeutics, purchased 1,333,333 shares at $15.00 each, investing approximately $20 million. The transaction increased Orbimed Advisors’ direct ownership by 35.15% to 5,126,891 shares, valued at about $76.9 million after the purchase. ETRA shares opened at $12.67, near their 52-week low of $12.50 and below the 52-week high of $15.50. Electra is a late clinical-stage biopharmaceutical company developing treatments for immune-mediated diseases and cancer. Electra Therapeutics, Inc. (NASDAQ:ETRA - Get Free Report) Director Orbimed Advisors Llc acquired 1,333,333 shares of the firm's stock in a transaction that occurred on Monday, September 21st. The shares were bought at an average price of $15.00 per share, with a total value of $19,999,995.00. Following the completion of the purchase, the director directly owned 5,126,891 shares in the company, valued at $76,903,365. The trade was a 35.15% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Electra Therapeutics Price PerformanceShares of ETRA stock opened at $12.67 on Thursday. Electra Therapeutics, Inc. has a 1-year low of $12.50 and a 1-year high of $15.50. About Electra Therapeutics (Get Free Report)Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's lead product candidate includes ipsoprubart. Electra Therapeutics Inc is based in SOUTH SAN FRANCISCO, Calif. See AlsoFive stocks we like better than Electra TherapeuticsChips to Bots: Qualcomm’s Agentic AI BreakoutCiena Fell 40%—Now One Analyst Sees 50% UpsideEnergy Transfer Taps the AI Power BoomViking's Obesity Edge May Be Staying Power, Not Weight LossThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Electra Therapeutics? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Electra Therapeutics and related companies. From Our PartnersHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredThe REAL Reason 2,000 Missiles Rained on IranTwo private meetings with U.S. Congressmen and weeks of research point to a surprising explanation for the rec...Behind the Markets | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | Sponsored Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | Sponsored Most Read This MonthInsiders Are Betting Big on These 3 Healthcare StocksRoper Technologies In Rebound and a Hot Buy Despite Insider SellingRocket Lab Insiders Are Selling—But Institutions Keep BuyingInsiders Signal Deep Value In DICK’s Sporting GoodsDestiny Tech100 (NYSE:DXYZ) CEO Buys 9,760 Shares of StockDestiny Tech100 (NYSE:DXYZ) COO Ethan Silver Purchases 753 SharesInsider Selling: Amazon.com (NASDAQ:AMZN) CEO Sells $254,770.00 in StockInsider Selling: Amazon.com (NASDAQ:AMZN) VP Sells 2,343 SharesRecent ArticlesGeorge Mattson Purchases 4,062 Shares of XOS (NASDAQ:XOS) StockHudson Technologies (NASDAQ:HDSN) Major Shareholder Hartree Partners, Lp Buys 2,502 SharesQuantum-Si (NASDAQ:QSI) CEO Jeffrey Alan Hawkins Sells 20,143 SharesPhilip Blake Hodge Purchases 30,000 Shares of Pine Cliff Energy (TSE:PNE) StockBristow Group (NYSE:VTOL) Insider Sells $16,211.00 in StockRimini Street (NASDAQ:RMNI) CMO David Rowe Sells 4,884 Shares of StockProficient Auto Logistics (NASDAQ:PAL) Director Purchases $24,060.00 in StockInsider Selling: Kimbell Royalty (NYSE:KRP) Insider Sells $24,327.00 in Stock